Evaxion A/S (EVAX) News Today $2.63 -0.02 (-0.75%) Closing price 04:00 PM EasternExtended Trading$2.64 +0.01 (+0.42%) As of 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EVAX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Evaxion A/S (NASDAQ:EVAX) Trading 3.1% Higher - Here's What HappenedJuly 12, 2025 | americanbankingnews.comEvaxion finalizes agreement with EIB to convert debt into equityJuly 11, 2025 | globenewswire.comEvaxion CEO Departs; CFO and Interim CEO AppointedJuly 1, 2025 | marketwatch.comEvaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolioJuly 1, 2025 | globenewswire.comEvaxion A/S Launches EVX-B4 Vaccine Development Program Targeting Group A Streptococcus InfectionsJune 27, 2025 | nasdaq.comEvaxion A/S (EVAX) Income Statement - Yahoo FinanceJune 26, 2025 | finance.yahoo.comEVAX AI Technology Produces New Vaccine CandidateJune 25, 2025 | msn.comEvaxion expands R&D pipeline with new vaccine program targeting Group A StreptococcusJune 25, 2025 | globenewswire.comEvaxion Biotech Receives Grant Funding to Develop New Polio VaccineJune 4, 2025 | msn.comEvaxion receives grant funding to design new polio vaccineJune 3, 2025 | globenewswire.comEvaxion Biotech A/S (NASDAQ:EVAX) Q1 2025 Earnings Call TranscriptMay 29, 2025 | msn.comEvaxion Biotech’s Earnings Call Highlights Progress and ChallengesMay 29, 2025 | msn.comEvaxion Biotech Reports Q1 2025 Progress and FinancialsMay 27, 2025 | tipranks.comEvaxion Biotech A/S (EVAX) Q1 2025 Earnings Conference Call TranscriptMay 27, 2025 | seekingalpha.comEvaxion Biotech: Evaxion announces business update and first quarter 2025 financial resultsMay 27, 2025 | finanznachrichten.deEvaxion announces business update and first quarter 2025 financial resultsMay 27, 2025 | globenewswire.comA Look at Evaxion Biotech's Upcoming Earnings ReportMay 26, 2025 | benzinga.comEvaxion Biotech: Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025May 25, 2025 | finanznachrichten.deEvaxion A/S to Host Conference Call for Q1 2025 Financial Results and Business Update on May 27, 2025May 25, 2025 | nasdaq.comEvaxion at Sidoti Conference: AI-Driven Drug Development StrategyMay 23, 2025 | investing.comEvaxion to announce business update and first quarter 2025 financial results on May 27, 2025May 23, 2025 | globenewswire.comEvaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01May 22, 2025 | globenewswire.comEvaxion A/S ADRMay 21, 2025 | wsj.comEvaxion Biotech A/S Announces Key Resolutions from April 2025 AGMMay 5, 2025 | tipranks.comEvaxion Reports Positive Data For Vaccine Candidate EVX-01April 30, 2025 | nasdaq.comEvaxion Biotech Reports 80% Tumor-Specific Immune Response from EVX-01 Cancer Vaccine in Phase 2 TrialApril 30, 2025 | nasdaq.com80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meetingApril 28, 2025 | globenewswire.comEvaxion Biotech: Evaxion to present at World Vaccine CongressApril 10, 2025 | finanznachrichten.deEvaxion to present at World Vaccine CongressApril 10, 2025 | globenewswire.comEvaxion Biotech A/S (NASDAQ:EVAX) Q4 2024 Earnings Call TranscriptApril 4, 2025 | msn.comEarnings call transcript: Evaxion Biotech Q4 2024 sees improved financialsApril 3, 2025 | uk.investing.comEvaxion Biotech’s Optimistic Earnings Call HighlightsApril 2, 2025 | tipranks.comEvaxion Biotech reports Q4 EPS (7c) vs (17c) last yearApril 2, 2025 | markets.businessinsider.comQ4 2024 Evaxion Biotech A/S Earnings CallApril 2, 2025 | finance.yahoo.comEvaxion Biotech Reports 2024 Financial Results and Strategic ProgressApril 1, 2025 | tipranks.comQ4 2024 Evaxion Biotech A/S Earnings Call TranscriptApril 1, 2025 | gurufocus.comEvaxion Biotech A/S (EVAX) Q4 2024 Earnings Call TranscriptApril 1, 2025 | seekingalpha.comEvaxion announces business update and full year 2024 financial resultsApril 1, 2025 | markets.businessinsider.comA Glimpse of Evaxion Biotech's Earnings PotentialMarch 31, 2025 | benzinga.comAgillic appoints new CFO Jack SørensenMarch 31, 2025 | finance.yahoo.comEvaxion to announce business update and full year 2024 financial results on April 1, 2025March 27, 2025 | globenewswire.comEvaxion Biotech: Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual MeetingMarch 25, 2025 | finanznachrichten.deEvaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual MeetingMarch 25, 2025 | globenewswire.comEvaxion Biotech files $50M ordinary shares offeringMarch 14, 2025 | markets.businessinsider.comEvaxion to present at numerous upcoming conferencesMarch 4, 2025 | markets.businessinsider.comEVAX Adds to Trial Due to Excellent ResultsFebruary 27, 2025 | msn.comEvaxion Biotech: Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data packageFebruary 25, 2025 | finanznachrichten.deEvaxion Biotech extends Phase 2 trial with EVX-01 to enhance clinical dataFebruary 25, 2025 | markets.businessinsider.comEvaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data packageFebruary 25, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX) and Harmony Biosciences Holdings (HRMY)February 20, 2025 | markets.businessinsider.com Get Evaxion A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address EVAX Media Mentions By Week EVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVAX News Sentiment▼0.630.96▲Average Medical News Sentiment EVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVAX Articles This Week▼12▲EVAX Articles Average Week Get Evaxion A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Lexaria Bioscience News Today HOOKIPA Pharma News Today Ernexa Therapeutics News Today Synlogic News Today Bullfrog AI News Today MetaVia News Today Briacell Therap News Today Leap Therapeutics News Today TherapeuticsMD News Today NKGen Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVAX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion A/S - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
